Yanlv Ren

No. 150, Haping Road, Nangang District
Harbin, 150081, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Unveiling heterogeneity and prognostic markers in ductal breast cancer through single-cell RNA-seq.

Unveiling heterogeneity and prognostic markers in ductal breast cancer through single-cell RNA-seq.

Journal: Cancer cell international
Published: November 01, 2023

Toremifene, an Alternative Adjuvant Endocrine Therapy, Is Better Than Tamoxifen in Breast Cancer Patients with CYP2D6*10 Mutant Genotypes.

Toremifene, an Alternative Adjuvant Endocrine Therapy, Is Better Than Tamoxifen in Breast Cancer Patients with CYP2D6*10 Mutant Genotypes.

Journal: Cancer research and treatment
Published: May 11, 2023

LncRNA GATA3-AS1 facilitates tumour progression and immune escape in triple-negative breast cancer through destabilization of GATA3 but stabilization of PD-L1.

LncRNA GATA3-AS1 facilitates tumour progression and immune escape in triple-negative breast cancer through destabilization of GATA3 but stabilization of PD-L1.

Journal: Cell proliferation
Published: December 08, 2019

Over-expression of CDX2 alleviates breast cancer by up-regulating microRNA let-7b and inhibiting COL11A1 expression.

Over-expression of CDX2 alleviates breast cancer by up-regulating microRNA let-7b and inhibiting COL11A1 expression.

Journal: Cancer cell international
Published: August 06, 2019

Over-expression of FSIP1 promotes breast cancer progression and confers resistance to docetaxel via MRP1 stabilization.

Over-expression of FSIP1 promotes breast cancer progression and confers resistance to docetaxel via MRP1 stabilization.

Journal: Cell death & disease
Published: May 23, 2018

MiR-23a promotes TGF-β1-induced EMT and tumor metastasis in breast cancer cells by directly targeting CDH1 and activating Wnt/β-catenin signaling.

MiR-23a promotes TGF-β1-induced EMT and tumor metastasis in breast cancer cells by directly targeting CDH1 and activating Wnt/β-catenin signaling.

Journal: Oncotarget
Published: January 21, 2017

Association of FGFR3 and FGFR4 gene polymorphisms with breast cancer in Chinese women of Heilongjiang province.

Association of FGFR3 and FGFR4 gene polymorphisms with breast cancer in Chinese women of Heilongjiang province.

Journal: Oncotarget
Published: July 05, 2015

HOXD13 methylation status is a prognostic indicator in breast cancer.

HOXD13 methylation status is a prognostic indicator in breast cancer.

Journal: International journal of clinical and experimental pathology
Published: May 28, 2015

Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators.

Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators.

Journal: World journal of surgical oncology
Published: November 13, 2012

Promoter hypermethylation of ARID1A gene is responsible for its low mRNA expression in many invasive breast cancers.

Promoter hypermethylation of ARID1A gene is responsible for its low mRNA expression in many invasive breast cancers.

Journal: PloS one
Published: October 07, 2012

Tamoxifen adherence and its relationship to mortality in 116 men with breast cancer.

Tamoxifen adherence and its relationship to mortality in 116 men with breast cancer.

Journal: Breast cancer research and treatment
Published: September 30, 2012
Showing 1-11 of 11

Last Updated: 09/26/2026